These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12376521)
1. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP. Qian GS; Kuang SY; He X; Groopman JD; Jackson PE Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1126-9. PubMed ID: 12376521 [TBL] [Abstract][Full Text] [Related]
2. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Jackson PE; Qian GS; Friesen MD; Zhu YR; Lu P; Wang JB; Wu Y; Kensler TW; Vogelstein B; Groopman JD Cancer Res; 2001 Jan; 61(1):33-5. PubMed ID: 11196182 [TBL] [Abstract][Full Text] [Related]
3. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses. Rivkina MB; Cullen JM; Robinson WS; Marion PL Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911 [TBL] [Abstract][Full Text] [Related]
5. [p53 gene mutation in hepatocellular carcinoma]. Jiang W; Lu Q; Pan G Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456 [TBL] [Abstract][Full Text] [Related]
6. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Jackson PE; Kuang SY; Wang JB; Strickland PT; Muñoz A; Kensler TW; Qian GS; Groopman JD Carcinogenesis; 2003 Oct; 24(10):1657-63. PubMed ID: 12869416 [TBL] [Abstract][Full Text] [Related]
7. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Hosono S; Chou MJ; Lee CS; Shih C Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978 [TBL] [Abstract][Full Text] [Related]
8. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China. Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907 [TBL] [Abstract][Full Text] [Related]
9. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China]. Zhang F; Zhu Y; Sun Z Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048 [TBL] [Abstract][Full Text] [Related]
10. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma]. Zhu MH Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744 [TBL] [Abstract][Full Text] [Related]
11. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205 [TBL] [Abstract][Full Text] [Related]
12. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145 [TBL] [Abstract][Full Text] [Related]
13. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China]. Ming L; Yuan B; Thorgeirsson SS Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852 [TBL] [Abstract][Full Text] [Related]
14. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Hussain SP; Schwank J; Staib F; Wang XW; Harris CC Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry. Lleonart ME; Kirk GD; Villar S; Lesi OA; Dasgupta A; Goedert JJ; Mendy M; Hollstein MC; Montesano R; Groopman JD; Hainaut P; Friesen MD Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2956-62. PubMed ID: 16365016 [TBL] [Abstract][Full Text] [Related]
16. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma]. Murakami Y Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551 [TBL] [Abstract][Full Text] [Related]
17. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211 [TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Hulla JE; Chen ZY; Eaton DL Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129 [TBL] [Abstract][Full Text] [Related]
19. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis. Kirby GM; Batist G; Fotouhi-Ardakani N; Nakazawa H; Yamasaki H; Kew M; Cameron RG; Alaoui-Jamali MA Int J Cancer; 1996 Sep; 68(1):21-5. PubMed ID: 8895534 [TBL] [Abstract][Full Text] [Related]
20. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation. Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]